Amphastar Pharma (AMPH) Reports Q3 Loss of $0.01/Share

Amphastar Pharma (NASDAQ: AMPH) reported Q3 EPS of ($0.01), versus ($0.07) reported last year. Revenue for the quarter came in at $63.9 million, versus $59.7 million reported last year.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.

You May Also Be Interested In

• H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
• Westport Fuel Systems (WPRT) Misses Q2 EPS by 64c
• Canterbury Park (CPHC) Misses Q2 EPS by 3c